1. Home
  2. DGLY vs OGEN Comparison

DGLY vs OGEN Comparison

Compare DGLY & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digital Ally Inc.

DGLY

Digital Ally Inc.

HOLD

Current Price

$0.76

Market Cap

1.3M

Sector

Technology

ML Signal

HOLD

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.87

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGLY
OGEN
Founded
2004
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3M
3.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DGLY
OGEN
Price
$0.76
$0.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
129.0K
98.1K
Earning Date
12-29-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,097,965.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.74
52 Week High
$1,200.00
$18.90

Technical Indicators

Market Signals
Indicator
DGLY
OGEN
Relative Strength Index (RSI) 36.92 48.15
Support Level $0.60 $0.74
Resistance Level $1.41 $0.88
Average True Range (ATR) 0.08 0.04
MACD 0.01 0.01
Stochastic Oscillator 34.35 77.71

Price Performance

Historical Comparison
DGLY
OGEN

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: